Evidence map›Paper›PMID 39230840›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2024

The SMILE scale: a wellness behavioral tool for patients with cancer.

Laura B Vater, Ali Ajrouch, Patrick O Monahan, Laura Jennewein, Yan Han, Ahmad Karkash, Nasser H Hanna

Abstract read
PubMed Publisher
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura B VaterDepartment of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, 535 Barnhill Drive, Suite 473, Indianapolis, IN, 46202, USA. lvater@iu.edu.ORCID http://orcid.org/0000-0002-5920-9576
Ali AjrouchDepartment of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, 535 Barnhill Drive, Suite 473, Indianapolis, IN, 46202, USA.
Patrick O MonahanDepartment of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA.
Laura JenneweinDepartment of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, 535 Barnhill Drive, Suite 473, Indianapolis, IN, 46202, USA.
Yan HanDepartment of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA.
Ahmad KarkashDepartment of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, 535 Barnhill Drive, Suite 473, Indianapolis, IN, 46202, USA.
Nasser H HannaDepartment of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, 535 Barnhill Drive, Suite 473, Indianapolis, IN, 46202, USA.

Funding

Betty Jo Throgmartin Research Fund Betty Jo Throgmartin Research FundHarry's PBR Research Fund Harry's PBR Research Fund
6 · The paper itself

Abstract

purposeAs cancer survivorship increases, there is a need for simple tools to measure and promote healthy behaviors. We created a wellness behavioral tool (the SMILE Scale) to encourage self-monitoring of wellness behaviors. This study aimed to determine the feasibility of collecting daily self-reported SMILE Scale data and weekly quality of life data among patients with cancer. We also aimed to measure the association between SMILE Scale responses and validated health-related quality of life (HRQOL) tools (PROMIS-29 + 2 and SymTrak-8) as a pilot test of the hypothesis that increased wellness behaviors may impact quality of life.

methodsWe surveyed 100 patients with cancer at the Indiana University Simon Comprehensive Cancer Center. Participants were asked to complete daily SMILE Scale assessments over a two-week period, as well as weekly PROMIS-29 + 2 and SymTrak-8 surveys. The primary endpoint was the SMILE Scale completion rate. Secondary endpoints in this single-arm pilot study included correlations between the SMILE Scale and other HRQOL tools.

resultsDaily completion rate of the SMILE Scale ranged from 57% to 65% of participants over a 14-day period. Among the 61% of participants who completed SMILE on day 1, 87% completed SMILE on 10 of 14 days. By end of study, participants who self-reported more wellness behaviors (i.e., higher daily SMILE scores) demonstrated significantly higher PROMIS physical health (p = 0.003), higher PROMIS mental health (p = 0.008), and lower (better) SymTrak total symptom burden (p = 0.006). Further, among those who completed at least 1 of 14 daily SMILE assessments, quality of life significantly improved over the two-week period for PROMIS mental health (p = 0.018) and SymTrak total symptom burden (p = 0.014).

conclusionThe SMILE Scale completion rate did not satisfy our pre-planned ≥70% threshold for feasibility; however, the rate for completing SMILE at least once during the 14 days (77%) met this threshold. Participants with higher average daily SMILE scores had significantly better scores across other validated HRQOL tools. While these results may be correlative and not causative, this suggests a potential physical and mental health benefit for delivering the SMILE Scale in clinical practice to help encourage healthy behaviors and warrants testing the SMILE Scale's impact in future studies.

Indexed as

Health BehaviorNeoplasmsQuality of LifeAdultAgedFeasibility StudiesFemaleHealth PromotionHumansIndianaMaleMiddle AgedPilot ProjectsPsychometricsSelf ReportSurveys and QuestionnairesCancer survivorshipHealth promotionLifestyle medicineQuality of lifeWellness behavior scale

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.